Teladoc Health, Inc. (TDOC): Price and Financial Metrics
Teladoc Health, Inc. (TDOC)
Today's Latest Price: $150.00 USD
Updated Apr 6 3:54pm
Add TDOC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 66 in Medical - Services
See all "A" rated Strong Buy stocks
TDOC Stock Summary
- With a market capitalization of $11,828,806,710, Teladoc Health Inc has a greater market value than 89.58% of US stocks.
- The price/operating cash flow metric for Teladoc Health Inc is higher than 99.64% of stocks in our set with a positive cash flow.
- TDOC's price/sales ratio is 21.38; that's higher than the P/S ratio of 95.18% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Teladoc Health Inc are EXAS, BL, CVLT, CDLX, and ZS.
- Visit TDOC's SEC page to see the company's official filings. To visit the company's web site, go to www.teladochealth.com.
TDOC Stock Price Chart More Charts
TDOC Price/Volume Stats
| Current price | $150.00 | 52-week high | $176.40 |
| Prev. close | $156.21 | 52-week low | $48.57 |
| Day low | $143.07 | Volume | 2,396,947 |
| Day high | $151.80 | Avg. volume | 2,856,710 |
| 50-day MA | $127.31 | Dividend yield | N/A |
| 200-day MA | $86.50 | Market Cap | 10.95B |
Teladoc Health, Inc. (TDOC) Company Bio
Teladoc Health provides telehealth services via mobile devices, the Internet, video, and phone to clients and their customers in the United States. The company was founded in 2002 and is based in Dallas, Texas.
TDOC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $150.00 | $134798.57 | 86193% |
Below please find a table outlining a discounted cash flow forecast for TDOC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Teladoc Health Inc ranked in the 100th percentile in terms of potential gain offered. Our DCF model suggests the stock is undervalued by 86616%; returns of such proportions should be viewed with some skepticism, though. In terms of the factors that were most noteworthy in this DCF analysis for TDOC, they are:
- The company has produced more trailing twelve month cash flow than only 22.99% of its sector Technology.
- The business' balance sheet suggests that 4% of the company's capital is sourced from debt; this is greater than merely 10.63% of the free cash flow producing stocks we're observing.
- Teladoc Health Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.77. This coverage rate is greater than that of just 9.52% of stocks we're observing for the purpose of forecasting via discounted cash flows.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 84501% |
| 1% | 85347% |
| 2% | 86193% |
| 3% | 87039% |
| 4% | 87885% |
| 5% | 88731% |
TRCK, ASX, PRSP, SGMA, and SEDG can be thought of as valuation peers to TDOC, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.
Top Stories View All
3 Energy Companies Likely to Survive the Downturn in Oil
2 Solid Companies That are Sitting on Plenty of Cash
Top 3 Stocks from the #1 Ranked Industry Revealed
4 “Beaten Down” Industrials to Buy for the Long Haul
3 Consumer Staple Stocks to Thrive from Coronavirus
View All Top Stories
Loading social stream, please wait...